Overview

Civamide Nasal Solution for Cluster Headache

Status:
Not yet recruiting

Trial end date:
2026-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of intranasally administered civamide nasal solution in the prevention of cluster headaches during an episodic cluster headache period.

Phase:

Phase 3

Details

Lead Sponsor:

Winston Laboratories

Treatments:

Capsaicin
Pharmaceutical Solutions